✦ LIBER ✦

Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

✍ Scribed by Jaclyn LoPiccolo; Gideon M. Blumenthal; Wendy B. Bernstein; Phillip A. Dennis

Book ID: 116413277
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 706 KB
Volume: 11
Category: Article
ISSN: 1368-7646
DOI: 10.1016/j.drup.2007.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting the PI3K/Akt/mTOR pathway: Eff

Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

✍ Jaclyn LoPiccolo; Gideon M. Blumenthal; Wendy B. Bernstein; Phillip A. Dennis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 706 KB

Targeting the PI3K–AKT–mTOR pathway: pro

Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises

✍ Timothy A Yap; Michelle D Garrett; Mike I Walton; Florence Raynaud; Johann S de 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 634 KB

Targeting the PI3K/Akt/mTOR Pathway for

Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy

✍ Justin Cidado, Ben Ho Park 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 322 KB

Expanding therapeutic targets in bladder

Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway

✍ Ching, Christina Barbara; Hansel, Donna Elizabeth 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

The PI3K/AKT/mTOR Pathway as a Therapeut

The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer

✍ Slomovitz, B. M.; Coleman, R. L. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 996 KB

Management of Metabolic Effects Associat

Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway

✍ Busaidy, N. L.; Farooki, A.; Dowlati, A.; Perentesis, J. P.; Dancey, J. E.; Doyl 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 834 KB